{
  "meta": {
    "title": "Glaucoma",
    "url": "https://brainandscalpel.vercel.app/glaucoma-f31d6417.html",
    "scrapedAt": "2025-11-29T18:33:42.872Z"
  },
  "questions": [
    {
      "id": 3322,
      "choices": [
        {
          "id": 13267,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
        },
        {
          "id": 13268,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></span></span></p>"
        },
        {
          "id": 13269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclopentolate</span></span></span></p>"
        },
        {
          "id": 13270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homatropine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the shortest acting mydriatic drug? </span></span></span></p>",
      "unique_key": "Q5666385",
      "question_audio": null,
      "question_video": null,
      "map_id": 35913,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tropicamide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide is an <strong>anticholinergic agent </strong>used as a<strong> mydriatic and cycloplegic drug </strong>for eye examinations. It has the <strong>fastest onset</strong> and the<strong> shortest duration of action </strong>compared to the other options, making it the <strong>shortest acting mydriatic.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because <strong>atropine has a very long duration of action</strong> in the eye, ranging from <strong>7-14 days. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cyclopentolate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as it has a<strong> slower onset of action</strong> and a<strong> longer duration</strong> than <strong>tropicamide. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Homatropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because it <strong>does not </strong>act as<strong> rapidly as tropicamide</strong> and has a <strong>longer duration of action.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tropicamide</strong> is the preferred <strong>mydriatic agen</strong>t for fundus examination due to its<strong> short acting duration</strong>, which is generally around <strong>4-6</strong> <strong>hours</strong>. It is especially <strong>useful over other anticholinergic agents</strong> when a <strong>quick return to normal pupil size</strong> is desired, such as in <strong>outpatient settings.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122143.jpg\" style=\"height:257px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 13268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3626,
      "choices": [
        {
          "id": 14483,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyrotoxicosis</span></span></span></p>"
        },
        {
          "id": 14484,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Variant angina</span></span></span></p>"
        },
        {
          "id": 14485,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine</span></span></span></p>"
        },
        {
          "id": 14486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol can be used in all of the following conditions except.</span></span></span></p>",
      "unique_key": "Q7024934",
      "question_audio": null,
      "question_video": null,
      "map_id": 35908,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Variant angina&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated in variant angina (Prinzmetal&#39;s angina) </strong>because it is a<strong> non-selective beta-blocke</strong>r that can <strong>exacerbate</strong> <strong>symptoms. Variant angina </strong>is caused by <strong>coronary artery spasms,</strong> and<strong> beta-blockers </strong>like <strong>propranolol </strong>can<strong> increase the risk</strong> of these <strong>spasms</strong> by leaving <strong>unopposed alpha-mediated vasoconstriction</strong>, potentially worsening the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thyrotoxicosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used in <strong>thyrotoxicosis</strong> to provide <strong>symptomatic relief</strong> from<strong> hyperthyroid symptoms </strong>such as <strong>tachycardia, anxiety, and tremors</strong>. It can also <strong>inhibit peripheral conversion of T4 to T3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Migraine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used as a<strong> prophylactic treatment for migraine</strong>. It helps <strong>reduce the frequency </strong>and <strong>severity of</strong> <strong>migraine attacks.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>can be used in the management of <strong>hypertension</strong>. It <strong>lowers blood pressure</strong> by <strong>reducing cardiac</strong> <strong>output</strong> and <strong>inhibiting</strong> <strong>renin</strong> release from the<strong> kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>therapeutic uses </strong>and <strong>contraindications of propranolol,</strong> a <strong>non-selective beta-blocke</strong>r. Recognizing that <strong>propranolol is contraindicated in variant angina </strong>due to its <strong>potential to worsen coronary artery spasms </strong>highlights the importance of considering the specific clinical context when selecting beta-blockers for treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications of &beta;-Blockers:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/88.jpg\" style=\"height:439px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 14484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3279,
      "choices": [
        {
          "id": 13095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial fibrillation </span></span></span></p>"
        },
        {
          "id": 13096,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia with AV block </span></span></span></p>"
        },
        {
          "id": 13097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsades&rsquo; de pointes </span></span></span></p>"
        },
        {
          "id": 13098,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with a history of hypertension has been managing his condition with metoprolol, a beta-blocker, to control his heart rate and blood pressure. Despite this treatment, his blood pressure remains above the target range. His physician decides to add verapamil, a calcium channel blocker, to his regimen to further control his blood pressure. Shortly after initiating verapamil, the patient reports symptoms of fatigue and dizziness. What complication can result from the addition of verapamil to a patient already on metoprolol treatment?</span></span></span></p>",
      "unique_key": "Q1641926",
      "question_audio": null,
      "question_video": null,
      "map_id": 35909,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bradycardia with AV block.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Both metoprolol and verapamil </strong>have <strong>negative chronotropic effects</strong>, meaning they <strong>decrease heart rate</strong>. <strong>Metoprolol </strong>does this by <strong>blocking beta-1 adrenergic receptors</strong>, primarily affecting the <strong>sinoatrial (SA) node</strong>, while <strong>verapamil blocks L-type calcium channels</strong>, which are critical for<strong> impulse conduction </strong>through the<strong> atrioventricular (AV) node.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adding verapamil </strong>to a patient already on <strong>metoprolol increases the risk </strong>of additive effects on <strong>heart rate and conduction</strong>. This can lead to <strong>bradycardia</strong>, which is an <strong>abnormally slow heart rate</strong>, and in <strong>more severe cases</strong>, can progress to<strong> AV block</strong>. AV block occurs when the <strong>electrical conduction between the atria and ventricles is impaired</strong>, potentially leading to <strong>serious heart rhythm abnormalities </strong>and symptoms such as<strong> dizziness and fatigue.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Atrial fibrillation:</strong> is<strong> not </strong>the most likely outcome of<strong> adding verapamil to metoprolol therapy, </strong>although <strong>verapamil is</strong> sometimes used to<strong> control ventricular rate i</strong>n patients <strong>with atrial fibrillation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C. Torsades&rsquo; de pointes:</strong> are a specific type of<strong> ventricular tachycardia </strong>often associated with a <strong>prolonged QT interval,</strong> which is <strong>not </strong>a typical <strong>side effect of either metoprolol or verapamil.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D. Tachycardia: </strong>&nbsp;or<strong> increased heart rate</strong>, would be unlikely as<strong> both drugs </strong>work to <strong>slow the heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the most appropriate answer in the context of this clinical scenario is b. <strong>Bradycardia with AV block</strong>, considering the pharmacological actions of<strong> both metoprolol and verapamil </strong>and the symptoms reported by the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When combining<strong> metoprolol</strong>, a <strong>beta-blocker, with verapamil, a calcium channel blocker,</strong> there is a significant <strong>risk of developing</strong> <strong>bradycardia with AV block</strong> due to their<strong> combined effect </strong>on <strong>slowing heart rate and impairing AV nodal conduction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8th/160</span></strong></span></span></p>",
      "correct_choice_id": 13096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3315,
      "choices": [
        {
          "id": 13239,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyoscine</span></span></span></p>"
        },
        {
          "id": 13240,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
        },
        {
          "id": 13241,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propantheline</span></span></span></p>"
        },
        {
          "id": 13242,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug is used for treatment of organophosphate poisoning? </span></span></p>",
      "unique_key": "Q4932707",
      "question_audio": null,
      "question_video": null,
      "map_id": 35910,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Atropine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>is an <strong>antimuscarinic agent </strong>that is used as an <strong>antidote</strong> in <strong>organophosphate poisoning</strong>. It counteracts the effects of <strong>excess</strong> acetylcholine due to <strong>anticholinesterase activity at muscarinic receptors</strong> but <strong>does not reactivate the cholinesterase enzyme inhibited by organophosphates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hyoscine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This drug is an <strong>antimuscarinic</strong>, similar to<strong> atropine</strong>, but is <strong>not</strong> typically used for <strong>organophosphate poisoning. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Physostigmine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This is a <strong>cholinesterase inhibit</strong>or and would worsen <strong>organophosphate poisoning. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Propantheline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; An <strong>antimuscarinic </strong>used for <strong>other indications, not </strong>typically for <strong>organophosphate poisoning.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For <strong>organophosphate poisoning,</strong> <strong>atropine</strong> is the <strong>specific antidote </strong>used to <strong>reverse the muscarinic symptoms</strong> such as <strong>excessive</strong> <strong>salivation, lacrimation, bradycardia, and hypotension </strong>due to the<strong> increased cholinergic activity.</strong></span></span></span></p>",
      "correct_choice_id": 13242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3328,
      "choices": [
        {
          "id": 13291,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
        },
        {
          "id": 13292,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
        },
        {
          "id": 13293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scopolamine</span></span></span></p>"
        },
        {
          "id": 13294,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyoscine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a tertiary amine derivative?</span></span></span></p>",
      "unique_key": "Q1204165",
      "question_audio": null,
      "question_video": null,
      "map_id": 35907,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;B) Glycopyrrolate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate </strong>is <strong>not a tertiary amine;</strong> it is a <strong>quaternary ammonium compound. Tertiary amines</strong> have the ability to<strong> cross the blood-brain barrier </strong>due to their structure, whereas <strong>quaternary ammonium compounds</strong>, such <strong>as glycopyrrolate</strong>, are<strong> unable to cross </strong>due to their <strong>charged nature.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, as it is a<strong> tertiary amine</strong> and <strong>can cross the blood-brain barrier,</strong> leading to <strong>central effects. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Scopolamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect,</strong> as it is a <strong>tertiary amine</strong> with <strong>central effects</strong> and is also known as <strong>hyoscine. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hyoscine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect, </strong>as it is <strong>another name for scopolamine</strong>, a<strong> tertiary amine </strong>with<strong> central actions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate</strong> is a <strong>quaternary ammonium compound,</strong> which <strong>cannot cross the blood-brain barrier,</strong> distinguishing it from <strong>tertiary</strong> <strong>amines </strong>like <strong>atropine and scopolamine (also known as hyoscine),</strong> which can have <strong>central nervous system effects.</strong></span></span></span></p>",
      "correct_choice_id": 13292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3348,
      "choices": [
        {
          "id": 13371,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></p>"
        },
        {
          "id": 13372,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></p>"
        },
        {
          "id": 13373,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></p>"
        },
        {
          "id": 13374,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tremors</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are adverse effects of salmeterol except? </span></span></span></p>",
      "unique_key": "Q3784326",
      "question_audio": null,
      "question_video": null,
      "map_id": 35911,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Hypoglycemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salmeterol </strong>is a <strong>beta 2 agonist.</strong> It can result in <strong>tachycardia, tremors and hypokalemia</strong> but <strong>not hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 agonists</strong> like <strong>salmeterol</strong> can lead to <strong>hypokalemia</strong> due to <strong>intracellular shifting of potassium.</strong> They can also cause<strong> tremors </strong>due to <strong>stimulation of beta-2 receptors in the skeletal muscles</strong> and <strong>tachycardia</strong> by affecting the <strong>heart.</strong> However, they<strong> do not</strong> typically cause<strong> hypoglycemia</strong>, which is <strong>more </strong>commonly associated with <strong>insulin </strong>or other <strong>glucose-lowering medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypokalemia:</strong> Can occur <strong>due to the intracellular shifting of potassium ions. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachycardia:</strong> Can result from<strong> beta-2 stimulation in the heart</strong>, leading to<strong> increased heart rate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors:</strong> Are a common side effect <strong>due to stimulation of beta-2 receptors</strong> in the <strong>skeletal muscles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Salmeterol,</strong> as a <strong>beta-2 agonist,</strong> <strong>does not</strong> typically cause <strong>hypoglycemia;</strong> its adverse effects related to <strong>beta-2 stimulation</strong> include <strong>tremors, tachycardia, and hypokalemia. </strong>Always monitor these potential side effects when prescribing or using beta-2 agonists.</span></span></p>",
      "correct_choice_id": 13371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3350,
      "choices": [
        {
          "id": 13379,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bethanechol</span></span></p>"
        },
        {
          "id": 13380,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsolusin</span></span></p>"
        },
        {
          "id": 13381,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin</span></span></p>"
        },
        {
          "id": 13382,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methacholine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with diabetes and COPD developed postoperative urinary retention. Which of the following drugs can be used for short-term treatment to relieve the symptoms of this person?</span></span></span></p>",
      "unique_key": "Q6062291",
      "question_audio": null,
      "question_video": null,
      "map_id": 35912,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bethanechol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of <strong>postoperative urinary retention, </strong>we must consider the<strong> drug</strong> that can effectively<strong> stimulate bladder emptying</strong> <strong>without</strong> exacerbating the<strong> patient&#39;s COPD. </strong></span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given drugs,<strong> only bethanechol</strong> is useful for treatment of<strong> post operative urinary</strong> <strong>retention</strong>. <strong>Though</strong> it<strong> can worsen COPD </strong>by causing<strong> bronchoconstriction </strong>but still this<strong> should be the answer,</strong> as no other drug given in options is <strong>useful in post operative retention.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation of options:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bethanechol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>drug</strong> is indeed used to<strong> treat urinary retention</strong>, as it <strong>stimulates muscarinic receptors</strong> in the<strong> bladder to</strong> <strong>induce contraction.</strong> Given that it is a <strong>direct cholinergic agonist, </strong>it could cause <strong>bronchoconstriction </strong>and <strong>would not</strong> be <strong>ideal </strong>for a patient with <strong>COPD, </strong>but it remains a treatment option specifically for<strong> urinary retention if the COPD </strong>is <strong>well-controlled and not severe.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tamsulosin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this drug is<strong> primarily used </strong>in the context of<strong> BPH, </strong>it <strong>does no</strong>t have a direct action to <strong>stimulate bladder</strong> <strong>emptying </strong>in the <strong>absence of BPH</strong> and is<strong> not used for postoperative urinary retention.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Terazosin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Similar to tamsulosin, terazosin </strong>is an <strong>alpha-blocker </strong>used in<strong> BPH</strong> and is <strong>not used for postoperative urinary</strong> <strong>retention </strong>unless there is <strong>concurrent BPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Methacholine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is <strong>primarily used for diagnostic purposes </strong>in conditions like<strong> asthma </strong>and is<strong> not used for treating</strong> <strong>urinary retention. </strong>Like<strong> bethanechol, </strong>it could potentially <strong>exacerbate COPD</strong> due to<strong> bronchoconstriction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bethanechol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the <strong>drug</strong> that is used for <strong>non-BPH</strong> related <strong>urinary retention, </strong>as it directly <strong>stimulates the detrusor muscle of the</strong> <strong>bladder</strong>. However, it would need to be<strong> used with caution </strong>in a patient with <strong>COPD. </strong>We need to <strong>weigh the benefits</strong> of using <strong>bethanechol for urinary retention </strong>against the risk of <strong>exacerbating the patient&#39;s COPD </strong>and<strong> monitor the patient closely.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given drugs,<strong> only bethanechol </strong>is useful for treatment of<strong> post operative urinary retention.</strong> Though it can <strong>worsen</strong> <strong>COPD by causing bronchoconstriction </strong>but still this should be the answer, as<strong> no other drug given in option</strong>s is useful in <strong>post operative retention.</strong></span></span></p>",
      "correct_choice_id": 13379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}